Integra LifeSciences Holdings Corp. (IART) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sanmina Corp.

Globus Medical, Inc.

Envista Holdings Corp.

Lantheus Holdings, Inc.

Glaukos Corp.

Merit Medical Systems, Inc.

Sotera Health Co.

Neogen Corp.

Haemonetics Corp.

Integra LifeSciences Holdings Corp.

Inari Medical, Inc.

Why is Integra LifeSciences Holdings Corp. ?

Poor long term growth as Operating profit has grown by an annual rate -5.42% of over the last 5 years

The company has declared Negative results for the last 4 consecutive quarters

NET PROFIT(Q) At USD 28.33 MM has Fallen at -57.21%
INTEREST(9M) At USD 82.97 MM has Grown at 28.1%
DEBT-EQUITY RATIO (HY) Highest at 170.1 %

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 36.58%, its profits have risen by 9.4% ; the PEG ratio of the company is 0.8

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Integra LifeSciences Holdings Corp. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Integra LifeSciences Holdings Corp.

36.58%

-0.68

63.90%

S&P 500

22.36%

1.70

13.18%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.57%

EBIT Growth (5y)

-5.42%

EBIT to Interest (avg)

5.10

Debt to EBITDA (avg)

3.74

Net Debt to Equity (avg)

1.04

Sales to Capital Employed (avg)

0.50

Tax Ratio

32.73%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

7.88%

ROE (avg)

10.40%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.73

EV to EBIT

14.66

EV to EBITDA

7.57

EV to Capital Employed

0.89

EV to Sales

1.45

PEG Ratio

0.83

Dividend Yield

ROCE (Latest)

6.10%

ROE (Latest)

10.43%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -0.92% (YoY

PRE-TAX PROFIT(Q)

At USD 29.98 MM has Grown at 55.17%

EPS(Q)

Highest at USD 0.06

-11What is not working for the Company

NET PROFIT(Q)

At USD 28.33 MM has Fallen at -57.21%

INTEREST(9M)

At USD 82.97 MM has Grown at 28.1%

DEBT-EQUITY RATIO (HY)

Highest at 170.1 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.54 times

Here's what is working for Integra LifeSciences Holdings Corp.

Pre-Tax Profit

At USD 29.98 MM has Grown at 55.17%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

EPS

Highest at USD 0.06

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by -0.92% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Integra LifeSciences Holdings Corp.

Net Profit

At USD 28.33 MM has Fallen at -57.21%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest

At USD 82.97 MM has Grown at 28.1%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio

Highest at 170.1 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 1.54 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Non Operating Income

Highest at USD 2.69 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income